HomeELTP • OTCMKTS
add
Elite Pharmaceuticals, Inc. Common Stock
Previous close
$0.50
Day range
$0.50 - $0.52
Year range
$0.10 - $0.75
Market cap
544.50M USD
Avg Volume
3.93M
P/E ratio
26.65
Dividend yield
-
Primary exchange
OTCMKTS
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 18.80M | 109.39% |
Operating expense | 4.61M | 46.44% |
Net income | 615.77K | -46.07% |
Net profit margin | 3.27 | -74.27% |
Earnings per share | — | — |
EBITDA | 4.29M | 122.23% |
Effective tax rate | 27.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.41M | -7.38% |
Total assets | 87.85M | 88.92% |
Total liabilities | 29.60M | 80.65% |
Total equity | 58.25M | — |
Shares outstanding | 1.07B | — |
Price to book | 10.00 | — |
Return on assets | 11.27% | — |
Return on capital | 13.88% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 615.77K | -46.07% |
Cash from operations | 3.14M | 216.04% |
Cash from investing | -1.66M | — |
Cash from financing | -174.91K | -104.42% |
Net change in cash | 1.31M | 4.72% |
Free cash flow | 168.00K | 105.41% |
About
Founded
1997
Headquarters
Website
Employees
64
